Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Active not recruiting × Prednisolone × Clear all

Phase

Phase 3 5 Phase 2 5 Phase 2/3 2 Phase NA 1 Phase 1/2 1 Phase 1 1

Status

Completed 7 Recruiting 2 Not yet recruiting 2 Withdrawn 1 Unknown 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphoma, Large B-Cell, Diffuse 1

Interventions

pembrolizumab 57 Cyclophosphamide 35 Nivolumab 33 Carboplatin 24 Gemcitabine 21 venetoclax 19 Specimen Handling 18 durvalumab 17 Paclitaxel 17 Rituximab 16 Magnetic Resonance Spectroscopy 16 Lenalidomide 16 Dexamethasone 16 Radiotherapy 15 fludarabine 14 Doxorubicin 14 Ipilimumab 13 atezolizumab 12 Vincristine 12 Biopsy 11 Bevacizumab 11 Etoposide 10 Calcium Dobesilate 10 Azacitidine 10 olaparib 9 Prednisone 9 Fluorouracil 9 Cisplatin 9 Cetuximab 9 fludarabine phosphate 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04914741 2024-08-12

COALITION

Peter MacCallum Cancer Centre, Australia

Phase 1/2 Active not recruiting

Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡